May 25, 2022
Life Sciences
  • Pfizer Inc. said it will sell 23 of its patent-protected drugs and vaccines at not-for-profit prices to 45 low-income countries beginning later this year, including treatments for cancer, heart conditions, and autoimmune diseases. In 2020, sales to developing countries in Africa and other emerging markets made up about one-fifth of Pfizer’s total sales, but the initiative could help build a large new market for prescription medicines. (Article here)